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 INTRODUCTION: 
 
Strangely visited people, 
All swoln and ulcerous, pitiful to the eye 
The mere despair of surgery, he cures, 
Hanging a golden stamp about their necks, 
Put on with holy prayers: and 'tis spoken, 
To the succeeding royalty he leaves 
The healing benediction 
                                                    —Macbeth, Act 4, Scene 3, 171-7 
These were the words from Shakespeare's Macbeth which describes the procedure 
of Royal Touch ceremony performed in medieval ages for treating tuberculosis 
patients!!!!!!!!!!! 
 Abdomen is one of the common sites of extra pulmonary involvement (6%). An 
increase in the incidence of pulmonary tuberculosis has led many to predict that 
there will be a corresponding increase in abdominal tuberculosis. In developing 
countries abdominal tuberculosis continues to be a common presentation of extra 
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pulmonary form. However, in developed countries due to increased standards of 
living the incidence of abdominal tuberculosis has become rare.  Since there is an 
increase in the incidence of Acquired Immuno-deficiency Syndrome (AIDS) 
recently, the incidence of abdominal  tuberculosis and other forms of Extra 
pulmonary tuberculosis are also expected to rise. 
Extra pulmonary form of tuberculosis is difficult to diagnose. Abdominal 
tuberculosis has bizarre, chronic and insiduous type of presentation and difficult to 
diagnose. Due to advent of laparoscopy, the diagnosis has been possible without 
laparotomy. Since there are diverse in clinical presentations, often with equivocal 
reports of the investigations and wide spread complications, often with prolonged 
morbidity and mortality, we have analyzed our patients to highlight the various 
aspects of abdominal tuberculosis in our setup. 
The purpose of this study is to find out the commonly encountered causes for 
emergency laparotomy in known tuberculosis patients presenting as acute abdomen 
and most frequently performed surgical interventions for the same in our setup. 
Rationale behind the study: 
Tuberculosis is one of the leading cause of morbidity and mortality all over the 
world, particularly in a developing country like India. Hence it is not only a health 
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concern to tackle this deadly & disabling disease but also a major social 
responsibility. 
Among the various clinical presentations  of  Tuberculosis, most require only 
medical management. But few,  including Abdominal Tuberculosis definitely  
requires surgical intervention. 
Abdominal tuberculosis is like a Pandora’s box with a variety of clinical 
presentations ranging from vague nonspecific abdominal pain to subacute 
obstruction to characteristic acute abdomen.  
 If  the pathology is diagnosed early , intervention could be done at an earlier stage 
by ATT thereby avoiding development of acute abdomen or the need for an 
emergency procedure. 
 But again, early diagnosis of abdominal tuberculosis is virtually impossible. Patients 
present only when the disease advances. Most times, they present to the emergency, 
with obstruction, perforation or abscess.  
This is the place, where surgical intervention comes into play. Not only these 
interventions relieve the patients of their symptoms, but also they provide tissue for 
diagnosis, thereby prompting the initiation of ATT. 
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Aims and Objectives: 
1. To evaluate the role of surgical interventions in cases of abdominal 
tuberculosis presenting as emergency 
2. To find out the most common surgical presentation of tubercular 
abdomen as acute abdomen in our setup  
3. To find out the most commonly performed surgical intervention in 
emergency presentations of  tubercular abdomen. 
 
 
Inclusion criteria: 
•  Known tuberculosis patient presenting as acute abdomen 
•  Patients presenting as acute abdomen who are found to have 
tuberculosis after biopsy report 
Exclusion criteria: 
•  Acute abdomen of all other etiologies 
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REVIEW OF LITERATURE: 
History of Tuberculosis: 
Since the ancient times Tuberculosis has been mentioned by numerous terms such 
as Consumption, Phthisis, Scrofula, Pott's disease,  the White Plague etc.  All these 
names tell the effect of the disease - Cachexia.   Analysis of  Mycobacterial 
Interspersed Repetitive Units inferred  that modern day Mycobacterium complex 
has evolved from a single species nearly 40,000 years ago, the period when Homo 
sapiens sapiens moved from Africa. And Mycobacterium bovis lineage dispersed 
approximately 6,000 years ago, the period of animal domestication and early 
farming. This disease was present in the fossils of Neo-lithic people.  
 
Timeline in discovery of Mycobacterium tuberculosis: 
Several breakthroughs happened in 19th century that lead to the discovery of 
Mycobacterium. 
René Laennec- did a  lot of studies on Tuberculosis. His works served as beacon for 
others to work upon. 
1869- Jean Antoine Villemin demonstrated that the disease was contagious. He 
extracted material from human cadavers died of tuberculosis and injected it to lab 
13 
 
rabbits, which got infected with tuberculosis after injection, thereby confirming the 
contagious nature of the disease. 
 24 March 1882- Robert Koch discovered Mycobacterium tuberculosis, or Koch's 
bacillus  used a new staining method  to  stain the sputum of  TB patients. Using 
blood serum he cultured the organism, which he inoculated in laboratory rabbits to 
reproduce the disease, thereby proving that the tuberculosis bacillus ,was the 
causative agent of tuberculosis. 
1890- Tuberculin, a purified protein derivative was developed from the bacteria as a 
means of immunization, but it was a failure. 
1908-Charles Mantoux discovered that injecting Tuberculin intra dermally was 
useful investigative tool in diagnosing tuberculosis. 
"If the importance of a disease for mankind is measured from the number of 
fatalities which are due to it, then tuberculosis must be considered much more 
important than those most feared infectious diseases, plague, cholera, and the like. 
Statistics have shown that 1/7 of all humans die of tuberculosis" 
                           —Die Ätiologie der Tuberculose, Robert Koch (1882) 
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Epidemiology: 
Between 2000 and 2020, it is estimated that, Nearly one billion people will be newly 
infected with TB, 200 million people will get diseased and at least 35 million lives 
will be lost all over the world.  
India is classified under Group IV countries along with sub-saharan countries, where 
the incidence and prevalence are very high. 
Incidence of tuberculosis  in India for the year of 2011 was 181 per 1,00,000 
population. The prevalence was 249 per 1,00,000 population. Of these, 19% were 
Extra pulmonary tuberculosis. 45% of patients with tuberculosis were patient with 
known HIV status. Abdominal tuberculosis was present in about 6% of the total 
patients.  
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Tamilnadu has very high reporting rates for tuberculosis, all over our country. 
 In our State, every year about 1.4 lakhs persons develop Tuberculosis, among which 
48,000 are sputum positive.  Nearly 50 per cent of tuberculosis (TB) patients in 
Tamil Nadu were found to be having either diabetes or pre diabetes conditions. 
 
Etiologic Agent: 
The most common organ that  Mycobacterium tuberculosis complex infects is the 
lungs. In up to one-third of cases other organs are involved. With proper treatment, 
TB is curable by drugs. Untreated, the disease is deadly  within 5 years of its onset  
in half of the cases. Disease is transmitted through droplet nuclei produced by 
patients with infectious pulmonary TB. 
It is an obligate intra cellular bacteria. 
Family-Mycobacteriaceae 
Order- Actinomycetales.  
 M. tuberculosis complex, 
     M. tuberculosis  - most common and important agent  
   Other organisms of the complex- M. bovis,  M. caprae, M. africanum,     
     M. microti , M. pinnipedii , and M. canetti . 
16 
 
M. tuberculosis, nonsporing, aerobic acid fast bacilli. Mycolic acid(long 
chained,cross linked fatty acids) are present in the bacterial cell wall.They are linked 
to the arabinogalactan and peptidoglycan molecules, present below. not only this 
produces acid fastness of the bacilli, but also they are responsible for very low 
permeability of the cell wall, & reduced susceptibility to most antibiotics. 
The molecule lipoarabinomannan is responsible for the bacteria-macrophage 
interaction and it aides in survival of the bacteria inside macrophage. 
                                     Acid-fast bacillus smear 
                                             
These Bacilli can be cultured ex-vivo using Löwenstein–Jensen medium & 
BACTEC medium. 
                                   Löwenstein–Jensen medium 
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                                      Bacterial cell wall structure: 
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Pathogenesis: 
From Exposure to Infection: 
Exposure leading to Infection-  it depends mainly on the exogenous factors,which 
are.... 
 Crowding, 
 Poor ventilation, 
 Over population. 
These exogenous factors determine the risk of acquiring M. tuberculosis infection. 
Organism is transmitted from a person to person by droplet nuclei.  Each cough 
may have as many as 3000 infectious nuclei. Apart from that it can be transmitted 
through the skin contact & placenta( of course both have minimal role only) 
PTB patients, who are sputum  positive are the ones who transmit the infection 
mostly. Majority of the patients spreading the disease have cavitary  lung disease but 
few have  laryngeal TB.  
Sputum smear–negative/culture-positive TB patients are less infectious. 
Culture-negative pulmonary TB and extrapulmonary TB wont infect any. Persons 
with both HIV infection and TB have less cavitations, and they are essentially less 
infectious than those without HIV infection.   
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From Infection to Disease: 
Infection leading to disease- it depends on endogenous factors, which are.... 
i. Innate immunity  
ii. Cell-mediated immunity (CMI). 
Primary TB – clinical disease that occurs after initial infection (common among 
young children and  immune compromised).  
Primary TB is severe and disseminated, but generally it has only low-level 
transmissibility.  
When infected in later years of life, mature immune system of the older age group 
will control the evolution into primary PTB. 
Secondary (or postprimary) TB   is often more infectious than primary disease, 
because of cavitation. This is most commonly due to reactivation of dormant bacilli. 
Of the patients infected primarily up to 10% will develop active TB in their lifetime, 
50% during the first year after infection. 
 HIV-infected patients have higher infection rate. 
In high prevalence regions, Secondary TB is due to reinfection of a previous 
individual.  
Majority of the PTB patients in our country are secondary TB patients. 
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Determinants of development of disease after infection include  
• Age 
• Immune status 
• HIV co-infection 
The disease can be cured in majority of patients.  
With effective, timely, and proper drugs, patients have a very high chance of cure. 
Infection and Macrophage Invasion: 
Host and Bacterial interaction starts with inhalation of droplet nuclei.Droplet nuclei 
are produced from the cough of the infected patients, which contain the bacteria. 
Upper airways trap and expel most of the bacteria (almost 90%) 
Only  <10% reach the alveoli. 
Inside alveoli, alveolar macrophages phagocytize the bacilli.  
Mycobacteria -macrophage interaction starts with the binding of the bacterial cell 
wall with macrophage cell-surface molecules, which are, 
• complement receptors, 
•  the mannose receptor,  
• the immunoglobulin GFc receptor,  
•  type A scavenger receptors 
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Complement pathway gets activated releasing C3 activation products such as C3b, 
which opsonize the bacilli making them tasty for the phagocytes to phagocytosize 
leading to phagosome formation. Inside the phagosome,  
M. tuberculosis  reduces acidification by inhibiting the accumulation of vesicular 
proton-adenosine triphosphatase. 
Lipoarabinomannan inhibits the increase of calcium inside the host  cell and affects 
phagosome-lysosome fusion, thereby leading to the survival of the bactera inside the 
host cell. 
Once bacilli survives inside the cell, it will start multiplying eventually rupturing the 
phagocyte and releases its contents. These contents include potent cytokines  which 
leads to recruitment of other uninfected phagocytic cells. 
These recruited cells continue the infection cycle by ingesting dying macrophages 
and their bacillary content, and in turn becoming infected themselves thereby 
expanding the infection. 
 
Virulence of Bacilli: 
  katG gene- gene responsible for producing catalase/peroxidase enzyme. This 
enzyme protects from oxidative stress& converts isoniazid to active form. 
Two key small protein antigens 
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(ESAT-6) --early secretory antigen-6  
(CFP-10) -- culture filtrate protein-10  
facilitate the egress of the bacterium from host cell. 
These proteins are absent in the vaccine strain M. bovis (BCG) has been shown to 
be a key attenuating mutation.  
Isocitrate lyase gene icl1  --encodes for an enzyme important   in the glyoxylate shunt 
This gene is required for long-term persistence of M. tuberculosis infection in mice 
with chronic TB.  
 carD -- gene that encodes for recently identified mycobacterial protein CarD  
This protein is essential for the control of rRNA transcription required for 
replication and persistence in the host cell.  
Loss of this gene exposes mycobacteria to oxidative stress, starvation, DNA damage, 
and ultimately sensitivity to killing by a variety of host mutagens and defensive 
mechanisms. 
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Host Response: 
In the first phase of infection, M. tuberculosis undergoes a period of extensive 
growth within naïve unactivated macrophages, and additional naïve macrophages 
leading to the formation of early granuloma. 
This is before the activation of cell mediated immunity. 
 M. tuberculosis has specific virulence mechanisms that subverts host cellular 
signaling and  elicits an early proinflammatory response that promotes granuloma 
expansion and bacterial growth during early phase. 
Mycobacterial protein ESAT-6 induces secretion of matrix metalloproteinase 9 
(MMP9) by nearby epithelial cells that are in contact with infected macrophages. 
MMP9 in turn stimulates recruitment of naïve macrophages, thus inducing 
granuloma maturation and bacterial growth. Disruption of MMP9 function results in 
reduced bacterial growth. 
Cytokines and bacterial cell products that  are produced repeatedly  from frequent 
lysis of cells, cause the migration of naive macrophages. 
These macrophages too will get infected  and subsequently infect the dendritic cells, 
which they recruit. 
 These cells enter the nearby draining lymph nodes and present the  antigens  from 
the bacteria to T lymphocytes.  
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This is the time of  development of Cell Mediated Immunity and humoral 
immunity.  
These initial stages of infection are usually asymptomatic. 
Host responses are of 2 types (which usually takes about 2-4weeks to start):  
1) Macrophage-activating CMI response& 
2) Tissue-damaging response 
The macrophage-activating response - T cell–mediated 
• activates macrophages that kill and digest the bacilli. 
• limits mycobacterial growth within macrophages  
• macrophages  stimulate T lymphocytes to release lymphokines 
• T lymphocytes mediate futhur inflammatory reaction  
• causes central caseous necrosis - lesion where activated macrophages occupy 
the lesion's middle thereby effectively neutralizing tubercle bacilli with 
minimal host tissue damage  
• Even inside the healed lesions, viable organism may remain dormant within 
macrophages for many years.  
• These lesions may undergo eventual calcification. 
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 The tissue-damaging response - delayed-type hypersensitivity (DTH) reaction 
• destroys unactivated macrophages that contain  bacilli 
• this is only in few percentage of patients where CMI is weak 
• produces early solid necrosis at the site of lesion 
• this will lead to tissue destruction 
• also there will be erosion of blood vessels, bronchioles and nearby lymph 
nodal spread 
• this might lead to the disseminated disease 
• in patients with immature immune system such as young children and in 
immuno compromised, the disease will be severe and often fatal 
                                    
 Both  responses  inhibit bacterial growth, but the balance between the two responses 
determine what sort of TB the patient is going to develop. 
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Specific immunity develops at a later stage where large number of 
activated macrophages accumulated near the primary lesion leading to the 
formation of granulomas. 
It is possible that an immune response capable of eradicating early 
infection may sometimes occur due to disabling mutations in 
mycobacterial genomes rendering their replication ineffective.  
Macrophages and Monocytes: 
Cell Mediated Immunity - provides partial protection against M. 
tuberculosis 
• T lymphocytes, Macrophages and Monocytes are responsible 
• Macrophages ingest bacilli and try to destroy them through a nitric 
oxide mediated mechanism 
• Also they release cytokines that recruit other inflammatory cells. 
• These include Interferon, Tumor Necrosis Factor and Interleukin-1 
Humoral immunity - provides very little role in protection. 
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T Lymphocytes: 
Alveolar macrophages, monocytes, and dendritic cells, all these cell 
process the bacilli they ingest and present the antigens to T lymphocytes. 
Both CD4+ and CD8+ T cells. 
The activation and proliferation of CD4+ T lymphocytes are important, 
because their role is crucial to host's defense against M. tuberculosis. 
Defective CD4+ T-lymphocytes fail to contain the proliferation of 
tubercle bacilli. 
  
Mycobacterial Lipids and Proteins: 
Blood borne Dendritic cells recognise the lipids  present on the bacillary 
cell wall through Toll like receptor(TLR) and lead to activation of innate 
immune system. 
Among the various antigens present in the bacilli, secreted antigens elicit 
T lymphocyte response.  
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Tuberculosis:  
• Pulmonary 
• Extra Pulmonary 
• Both 
  80% were pulmonary in non HIV patients. 
But 60% of HIV patients with TB  have both pulmonary and 
extrapulmonary TB or extrapulmonary TB alone. 
PTB: 
Pulmonary TB can be  
• primary or (disease following first infection) 
•  postprimary (adult-type, secondary).(disease following either 
reactivation or re infection)  
 
 
30 
 
 
                    SYSTEMIC SPREAD OF TB FROM LUNGS 
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Primary PTB: 
Primary PTB -occurs  after the initial infection, often seen in children. 
Affects the middle and lower lung zones and patient may have pleuritic 
chest pain but most patients are asymptomatic. Initial infection (the Ghon 
focus) is a peripheral lesion, accompanied by transient hilar or 
paratracheal lymphadenopathy. Pleural reaction may also occur if the 
focus is sub pleural. The Ghon focus+ regional lymphadenopathy, is 
called Ghon complex. 
If the Cell Mediated Immunity is immature or impaired  primary  PTB  
progresses  rapidly (progressive primary TB). 
 
 Postprimary (Adult-Type) PTB: 
Reactivation or secondary TB postprimary TB - is adult-type TB. 
Post primary can either due to re activation or re infection. 
 The lung disease varies, from small infiltrates to extensive cavitary 
disease.  
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Extrapulmonary TB: 
Extra pulmonary tuberculosis involves the following sites with decreasing order of 
frequency.  
• Lymph nodes, 
•  Pleura, 
•  Genitourinary tract,  
• Bones and joints,  
• Meninges,  
• Gastro intestinal,  
• Pericardium.... etc 
Any organ systems can be affected.  
Extrapulmonary TB is seen more common today than earlier. 
Lymph Node TB (Tuberculous Lymphadenitis): 
Lymph nodes are most common presentation of extrapulmonary TB in both HIV & 
non HIV patients.  
Patients present with painless swelling of the lymph nodes,  commonly involving 
posterior cervical and supraclavicular sites (scrofula).  
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Pleural TB: 
Contributes to 20% of extrapulmonary cases. Presents as 
•  Isolated pleural effusion & 
• Pleurisy. 
Patient may have symptoms such as fever, pleuritic chest pain, and dyspnea. Pleural 
fluid analysis essential for the diagnosis. The fluid is straw colored, hemorrhagic, 
exudative. 
Tuberculous empyema is a less common complication of pulmonary TB. Drainage 
is usually required along with ATT. It may lead to severe pleural fibrosis and 
restrictive lung disease. Removal of the thickened visceral pleura (decortication) is 
occasionally necessary to improve lung function. 
 
TB of the Upper Airways: 
Secondary to  advanced  pulmonary TB with cavitary lesions. It involves the larynx, 
pharynx, and epiglottis. Hoarseness of voice, change of voice, difficulty in 
swallowing, chronic productive cough are the symptoms. Often it mimics carcinoma 
of larynx. 
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Genitourinary TB: 
Genitourinary TB - 10–15% of all extrapulmonary cases. 
Any part of the genito urinary tract can be involved. Dysuria, hematuria, and flank or 
abdominal pain are common symptoms. Urinalysis is abnormal  in 90% of cases, 
with pyuria ( pyuria in acidic urine without any growth)  and hemeturia. 
 Genital TB is present commonly in females than males.  
In females it affects the fallopian tubes& endometrium. 
It might cause Infertility, pelvic pain, and menstrual abnormalities.  
 In males genital TB preferentially affects the epididymis, which may drain externally 
through a fistula. 
It can also cause orchitis and prostatitis.  
Genitourinary TB responds well to chemotherapy. 
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Skeletal TB: 
TB of the bones and joints are involved in 10% of extra pulmonary TB.  
Disease is due to reactivation of previous foci or spread from adjacent paravertebral 
lymph nodes.  
Hip and knee joints are most commonly affected. 
Spinal TB  involves two or more adjacent vertebral bodies.  
 A paravertebral "cold" abscess may also occur.  A catastrophic complication of Pott's 
disease is paraplegia. Paraparesis due to a large abscess is a medical emergency and 
requires rapid drainage. Skeletal TB responds to chemotherapy, but severe cases 
may require surgery. 
Pericardial TB: 
Pericardium is affected in following ways 
• direct extension from adjacent mediastinal/hilar lymph nodes or 
• hematogenous spread. 
The effusion is exudative in nature, with a high count of lymphocytes and 
monocytes. Hemorrhagic effusion is common.  
TB myocarditis is due to direct extension from the pericardium. It is very rare and 
very fatal.  
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Miliary or Disseminated TB: 
Miliary TB is due to hematogenous dissemination of Mycobacterium 
tuberculosis. 
• In children -primary infection, 
• In adults -reinfection or reactivation.  
The lesions are yellowish granulomas which resemble millet seeds and are 
1–2 mm in diameter.  
 Fever, night sweats, anorexia, weakness, and weight loss are presenting 
symptoms in the majority of cases.  Physical findings include 
hepatomegaly, splenomegaly, and lymphadenopathy.  
Gastrointestinal TB: 
Any part of the gastrointestinal tract can be affected by tuberculosis. 
GIT is the sixth most frequent site of extra pulmonary involvement. 
Spread is due to swallowing of sputum with direct seeding, hematogenous 
spread, or ingestion of milk from cows affected by bovine TB.  
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Various presentations of abdominal tuberculosis are 
   1. Intestinal 
              1) Ileo- Caecal tuberculosis 
                      a) Ulcerative type 
                      b) Ulcero- Hyperplastic 
                      c) Hyperplastic 
              2) Ileal tuberculosis - strictural  disease 
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2.  Peritoneal tuberculosis 
             1) Acute 
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          2) Chronic 
                    a) Ascitic type 
                    b) Encysted (loculated) type 
                    c) Plastic (Fibrous/Adhesive) type 
                    d) Purulent type 
3.  Mesentric tuberculosis 
4. Ano-Recto-Sigmoidal tuberculosis 
5. Visceral Miliary Tuberculosis 
6. Omental tuberculosis 
7. Others 
      Retro Peritoneal 
      Gastro- Duodenal 
The disease is characterized by the presence of transverse ulcers of the mucosa but 
the inflammatory process maybe transmural. 
Stricture of the intestine, particularly that of ileum is common. 
Terminal ileum and the cecum are most commonly involved sites though it can 
affect  anywhere in GIT. Abdominal pain, swelling, obstruction,   and a palpable 
mass in the abdomen are common findings at presentation. 
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Tuberculous peritonitis is due to the  
 Direct spread of tubercle bacilli from lymph nodes and viscera  
 Hematogenous seeding. 
  Nonspecific abdominal pain, fever, and ascites. 
 
1) Mesenteric lymph nodes will be enlarged, matted and may often undergo 
caeseous necrosis, thereby leading to tubercular abscess. 
2) Omental thickening and peritoneal tubercles are other presentations. 
 In tuberculous peritonitis, paracentesis reveals an exudative fluid with a high protein 
content and leukocytosis that is usually lymphocytic (although neutrophils 
occasionally predominate). The yield of direct smear and culture is relatively low; 
culture of a large volume of ascitic fluid can increase the yield, but peritoneal biopsy 
(with a specimen best obtained by laparoscopy) is often needed to establish the 
diagnosis. 
Ascitic fluid analysis have the following characteristics: 
a. Appearence: straw coloured fluid,  
b. Protein content: High, 
c. Serum ascitis albumin gradient < 1.1 g/dl, 
d. Cytology: predominantly lymphocytic cells,  
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e. Adenosine deaminase > 36 U/l.  
In cases of equivocal diagnosis Diagnostic Laparoscopy is a very useful.  
In GIT  the ileocaecal region is most commonly affected by tuberculosis. 
Patients present with a palpable mass in the right iliac fossa with/without  
obstruction/perforation cachexia.    
Other rare  presentations are  
i. Oesophageal ulcer  
ii.  Gastroduodenal tuberculosis,  
iii. Colonic tuberculosis,  
iv. Rectal stricture and multiple perianal fistulae due to rectal and anal 
involvement.  
     < 25 per cent of patients have lung lesions in chest X rays. 
Fever, weight loss, anorexia, and night sweats are also common.  
Abdominal TB often mimics Crohn’s disease. 
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                          CECT IMAGE OF ILEO CECAL TUBERCULOSIS 
                           
                      X RAY ABDOMEN- INTESTINAL OBSTRUCTION 
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                                                 USG ABDOMEN 
             
  
 
                                   
 Investigations: 
i. ultrasonography, 
ii. small bowel barium meal, 
iii.  barium enema,  
iv. computed tomographic scan and  
v. colonoscopy.  
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In acute presentations of abdominal tuberculosis patients usually present with fever 
and abdominal pain, vomiting, consipation/ obstipation with abdominal distention  
suggesting intestinal obstruction. 
Management: 
Surgical interventions performed were, 
•  Stricturoplasty 
• Resection Anastomosis of Ileal stricture with/without proximal diversion 
ileostomy 
• Limited Resection of Ileum, Caecum & Ascending Colon with Ileo-Ascending 
anastomosis with/without proximal diversion ileostomy 
• Right Hemicolectomy with/without proximal diversion ileostomy 
• Extended Right Hemicolectomy 
• Mesentric Lymph Node biopsy 
• Diversion ileostomy. 
Stricturoplasty: 
The wall of the strictured bowel is incised longitudinally. Reconstruction is 
performed by closing the defect.This is usually done for very small strictures. 
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Resection and anastomosis: 
The stricturous  portion along with the proximal and distal portion are 
resected for a short length with end to end primary anastomosis. 
Covering proximal diversion ileostomy can be done. 
Limited Resection: 
For Ileo ceacal tuberculosis, the diseased portion, along with small 
distance of ileum and ascending colon is   resected and end to side or 
end to end primary anastomosis is done. 
 Diversion Ileostomy: 
When the peritoneal cavity is grossly contaminated or when there is 
difficulty in performing a definitive procedure, diversion procedures 
can be performed to relieve obstruction. 
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Role of  Diagnostic Laparoscopy: 
Wth the increased availability  of laparascopy,  diagnostic laparascopy has become a 
principle modality of investigation for many non specific abdominal complaints, after 
all other non invasive tests do not show any conclusive evidence.  
The advantage of this minimally invasive technique is that it avoids unnecessary 
laparotomies and at the same time helps to diagnose abdominal tuberculosis at an 
early latent stage. 
Moreover  it could  be used for intervention including taking biopsy for tissue proof 
in doubtful cases.  
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ATT REGIMEN: 
RNTCP has revised the previous regimen thereby discontinuing Category III. 
 
 
H- ISONIAZID                         Z- PYRAZINAMIDE           S- STREPTOMYCIN 
R- RIFAMPICIN                       E- ETHAMBUTOL 
Just providing anti-TB medication is not sufficient to ensure that patients are cured. 
The DOTS strategy ensures that infectious TB patients are diagnosed and treated 
effectively till cure, by ensuring availability of the full course of drugs and a system 
for monitoring patient compliance to the treatment.  
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Directly Observed Treatment, Short-course (DOTS) 
 
The DOTS strategy was  implemented under the Revised National Tuberculosis 
Control Programme (RNTCP) in India, for comprehensive TB control. 
Every day under the RNTCP, more than 15,000 suspects are being examined for 
TB.  
The diagnosis of these patients and the follow-up of patients on treatment is 
achieved through the examination of more than 50,000 laboratory specimens. As a 
result, each day about 3,500 patients are started on treatment, stopping the spread of 
TB in the community.  
As a result of rapid expansion in diagnostic facilities, the proportion of sputum- 
positive cases confirmed in the laboratory are double that of the previous 
programme and is on par with international standards. Despite the rapid expansion, 
overall performance remains good and in many areas is excellent. Treatment success 
rates have tripled from 25% in the earlier programme to 86%in RNTCP. 
 
TB is the most common opportunistic infection in people living with HIV virus. As 
the HIV breaks down the immune system, HIV- infected people are at greatly 
increased risk of TB.  
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Without HIV, the lifetime risk of developing TB in TB-infected people is 10%, 
compared to at least 50% in HIV co-infected.  
HIV is also the most powerful risk factor for progression from TB infection to TB 
disease. TB in turn accelerates the progression of HIV to AIDS and shortens the 
survival of patients with HIV infection. 
With large numbers of HIV-positive individuals in India, it is likely that HIV may 
worsen the TB epidemic in the absence of a robust TB control programme. 
However, even among HIV-infected people, TB can be cured. Directly Observed 
Treatment, Short-course (DOTS) is as effective among HIV- infected TB patients as 
among those who are HIV negative.   
 
Multi-drug-Resistant Tuberculosis (MDRTB) : 
 
MDR TB refers to strains of the bacterium which are proven in a laboratory to be 
resistant to the two most active anti-TB drugs, isoniazid and rifampicin. Treatment of 
MDR TB is extremely expensive, toxic, arduous, and often unsuccessful. 
 
DOTS has been proven to prevent the emergence of MDR TB, and also to reverse 
the incidence of MDR TB where it has emerged. MDR TB is a tragedy for 
individual patients and a symptom of poor TB management. The best way to 
confront this challenge is to improve TB treatment and implement DOTS. 
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Introduction of DOTS-Plus: 
The first WHO endorsed DOTS-Plus programmes began in 2000. DOTS-Plus 
pilot projects have demonstrated the feasibility and effectiveness of MDR-TB  
treatment.  
DOTS-Plus projects have multiplied rapidly.  
Multi-drug resistant Tuberculosis (MDR-TB) is defined as resistance of 
Mycobacterium tuberculosis to Rifampicin and Isoniazid, two of the most effective 
anti-tubercular drugs for treatment of Tuberculosis.  
MDR-TB levels are about 3%  in new cases and 12%-17% in re-treatment cases.  
Although the level of MDR-TB in the community is low, in relation to percentages 
and proportions it translates into large absolute numbers.  
To address this issue the Revised National Tuberculosis Control Programme 
(RNTCP) has initiated the DOTS Plus strategy for appropriate management of 
MDR TB patients and to prevent the propagation and dissemination of MDR-TB.  
Category IV regimen: 
Intensive phase: 
Kanamycin, Ofloxacin, Ethionamide, Pyrazinamide, Ethambutol, Cycloserine (6-9 
months)  
Continuation phase. 
Ofloxacin, Ethionamide, Ethambutol, Cycloserine (18 months) 
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Materials and Method: 
                   This study was conducted in RGGGH & Madras medical college, 
Department of  general surgery during the period of August 2012 – December 2012. 
Informed written consent was obtained from all the patients. All the base line 
investigations comprising haematological and biochemical parameters had been 
done. about  60 patients who were admitted to the emergency department between 
may 2010 and june 2012 with acute abdominal complaints  were taken for the study. 
The diagnosis of abdominal tuberculosis were made by clinical findings and 
investigational reports including histo pathological report of the specimen.  All the 
patients underwent emergency X ray chest PA view, X ray abdomen erect view, 
USG  abdomen. Some selected patients were subjected to CECT abdomen. The 
surgical procedures done were, laparotomy and mesentric node biopsy/ omental/ 
peritoneal biopsy, limited resection of ileum, cecum and ascending colon with ileo 
colic anastomosis with & without proximal diversion, resection and anastomosis of 
ileum with or without proximal diversion, stricturoplasty, adhesiolysis with peritoneal 
biopsy. With consent patients were subjected to HIV 1&2 ELISA. All the patients 
underwent sputum AFB post operatively to look for pulmonary foci and patients 
were subjected to Cat 1 or Cat 2 ATT as per pulmonary involvement. Patients were 
followed up post operatively till the completion of ATT. 
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Data Collected: 
Preoperative demographic and clinical data, details of the surgical 
procedure, postoperative course, and complications were collected 
prospectively. Various presentations of tubercular abdomen along with 
the procedure done were analyzed. Post operatively patients were 
followed up to look for development of complications. All the patients 
were discharged after starting ATT. Complications included  
wound infection, development of adhesions, anastomotic leak, respiratory 
complications, duration of hospital stay. 
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Results: 
 
• Sixty two cases of acute abdomen were taken up for study. 
• All cases were taken up for emergency laparotomy on the day of 
admission 
• Stricture of ileum was the most common presentation in emergency 
followed by ileo cecal tuberculosis (46%) 
• Most commonly performed procedure was resection anastomosis 
(31%) 
• All the patients were started on ATT on a average of 15 th post 
operative day. 
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                The following observations were made…..
 
 
 
Of 62 patients 44 were male and 18 were female, which were 71% and 29% 
respectively.  
 
 
 
 
 
 
 
0%
20%
40%
60%
80%
100%
120%
gender
distribution
GENDER DISTRIBUTION 
MALE 71% FEMALE 29%
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Among the patients studied, 20 were from the age group of 21-30yrs corresponding 
to 32%. 
Age group 11-20= 8(13%) 
Age group 21-30=20(32%) 
Age group 31-40=16(26%) 
Age group 41-50=15(24%) 
Age group 51-60=3(5%) 
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Among the patients, only 2 had HIV infection, making it about 3% of total. 
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7 patients had h/o of pulmonary tuberculosis previously, who had completely 
finished their ATT. 
 
 
 
89% 
11% 
INCIDENCE OF ABD TB IN PRIOR PTB 
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NON PTB PRIOR PTB
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Mortality among the treated patients were 6%( 4 patients). 
All the deaths were due to septicemia. 
 
 
MORTALITY
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Morbidity  was  39% (24 patients) 
Most common factor responsible for morbidity was wound infection. 
Other complications included respiratory tract infection and anastomotic leak. 
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Various presentations of tubercular abdomen were 
• Ileo ceacal tuberculosis  =17(28%) 
• Ileal Stricture                 =28(46%) 
• Peritoneal tuberculosis   =12(19%) 
• Tubercular Abscess       =3(4%) 
• Other presentations       =2(3%) 
• Transverse colon stricture=1 
• Retroperitoneal Lymphadenopathy=1 
0%
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80%
100%
ABD TB PRESENTATIONS
28% 
46% 
19% 
4% 3% 
IC TB ILEAL STRICTURE PERITONEAL TB TUBERCULAR ABSCESS OTHERS
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Surgical interventions performed were, 
•  Stricturoplasty =8(13%) 
• Resection Anastomosis of Ileal stricture with/without proximal diversion 
ileostomy =19(31%) 
• Limited Resection of Ileum, Caecum & Ascending Colon with Ileo-Ascending 
anastomosis with/without proximal diversion ileostomy =6(10%) 
• Right Hemicolectomy with/without proximal diversion ileostomy =10(16%) 
• Extended Right Hemicolectomy =1(2%) 
• Lymph Node biopsy =16(26%) 
• Diversion ileostomy =2(3%) 
13% 
31% 
10% 
16% 
2% 
26% 
3% 
0%
5%
10%
15%
20%
25%
30%
35%
STRICTUROPLASTY
RESECTION ANASTOMOSIS
LIMITED RESECTION
RT HEMICOLECTOMY
EXT RT HEMICOLECTOMY
LYMPH NODE BIOPSY
DIVERSION ILEOSTOMY
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Of the patients diagnosed with abdominal tuberculosis about 17(27%)  had 
evidence of  pulmonary  tuberculosis. Among the patients diagnosed with 
PTB, 2 out of 17 had history of prior tuberculosis. 
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Diabetes mellitus was present in 21% of the patients(13 patients). 
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Discussion: 
Age Distribution: 
Among the patients studied, majority of abdominal tuberculosis was present  in the 
age group of 21-30 yrs (32%) 
This is followed by higher incidence among 31-40 yrs(26%) 
Most common age group affected by PTB belong to 21-40 yrs, the so called working 
age group. 
Our study of Abdominal tuberculosis also reports the same age wise distribution, 
reflecting the same as in the distribution of Pulmonary TB. 
Gender Distribution: 
Male patients were majority (71%) 
Females(29%) 
Male female ratio is 3:1. 
Socio economic Distribution: 
Majority of the disease is among lower socio economic group (83%). 
This reflects the overall incidence of tuberculosis. 
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History of prior tuberculosis: 
Of the 62 patients presented,  
7(11%) had previous history & treatment for pulmonary Tuberculosis. 
All the patients had complete course of ATT for PTB and there was no default or 
relapse.  
Among the 62 patients presented about 35 patients had prior history of abdominal 
pain, which were treated without any approximate investigations. This is about 22%. 
Among these patients,(35) about 10 were found to have PTB post operatively, about 
30%, who were diagnosed with sputum smear for AFB. 
Presumptive treatment of these patients would have decreased the incidence of 
abdominal tuberculosis also in this sub group of patients(p<0.05). 
 
PTB diagnosed after surgery : 
After surgery, 17(27%) patients were found to have pulmonary tuberculosis. 
All these patients underwent CXR-PA view, sputum for AFB. 
15 of the patients  were newly diagnosed with pulmonary tuberculosis. 
2 of the patients previously had PTB. 
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Abdominal tuberculosis is  present as a single entity  in majority of the patients(73%) 
in our study group, without any pulmonary involvement. 
Though coexisting PTB was present in a relatively small proportion of 
patients(27%), the presence of PTB in them indicates a more disseminated form of 
.disease, requiring intensive follow up. 
Types of presentations: 
 In our study, Ileal stricture was the most common presentation. 
 Though literature says ileo caecal tuberculosis is the most common type, our 
study analyzed only the acute presentations, where obstruction was the most 
common clinical presentation. 
 Two rare types of presentations, such as transverse colon stricture and retro 
peritoneal lymphadenopathy were also seen. 
 Even for the strictures, we preferred resection anastomosis than stricturoplasty, as 
the disease is an ongoing process. 
 Resection anastomosis was the most frequently performed procedure for 
strictures. 
 They have the advantage of removing the entire diseased portion of the small 
bowel, when compared to stricturoplasty, where the diseased portion remains. 
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 Not only it has the advantage of removing the disease, but also the decrease in the 
complications like anastomotic leak (impaired healing in the stricturous portion) 
and recurrence of the obstruction (Also the the ATT regimen would have 
increased the inflammation thereby causing subsequent fibrosis and might have 
lead to obstruction again) 
Morbidity: 
Wound infection was the most common postoperative complication, causing 
increased morbidity.  
Patients newly diagnosed as having PTB had increased incidence of respiratory 
complication. These respiratory complications include, pneumonia, pleural effusion,  
fall of saturation making the patient dependent on a mechanical ventilatory support. 
 These increase in respiratory complications in new PTB patients can be attributed 
to the active disease. 
All these patients were given appropriate antibiotics after performing wound  swab, 
sputum culture& sensitivity. 
Anastomotic leak which is normally at a rate of 2- 4 % was relatively high among our 
patients, (about 25%). 
Patients, who underwent stricturoplasty had very high rates of leak, about 62.5%. 
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Even for the other procedures, it was significantly high, resection 
anastomosis(10.5%) & Right Hemicolectomy(10%). 
The performance of proximal diversion, significantly reduced the complication due 
to anastomotic leak. 
Proximal diversion was performed in about, 
11% (2/19) of resection anastomosis (non diversion leak rate was 11%), 
33% (2/6) of limited resection group (non diversion leak rate 0%), 
40% (4/10) of right hemicolectomy group (non diversion leak rate 10%) & 
100% (1/1) of ext.right hemicolectomy group (non diversion leak rate 0%). 
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Mortality: 
Of the patients operated, 4 patients died. All the death were due to 
septicemia.  It is about 6% of the total patients studied. 
 
 
S. 
N
O 
Name Age/se
x 
Co 
morbidit
y 
shoc
k 
Symptoms
- dur 
diagnosis Procedure 
done 
Cause of death 
1. THANGAVEL 39/M - - 3 DAYS ILE.STRI
C 
RESEC ANAS ANAS. 
LEAK/SEPTICEMI
A 
2. KOTTI 46/M - - 4 1/2 
DAYS 
IC TB DIV. ILEO SEPTICEMIA 
3. KAMALA 34/F - + 2 DAYS IC TB/DIL 
SMA 
BOW 
LOOPS 
RT 
HEMIC0LEC
/ DIV ILEO 
SEPTICEMIA 
4. KARUPANNA
N 
27/M - + 2 DAYS ILE. 
STRIC 
RESEC ANAS SEPTICEMIA 
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Post operative ATT: 
All the patients underwent  postoperative evaluation for pulmonary tuberculosis. 
The investigations performed were,  CXR PA view, sputum smear for AFB & 
sputum culture for AFB. 
On average, ATT was started on 16 th pod. 
All the patients were treated with Cat I ATT. 
The problem with Extra pulmonary tuberculosis is the difficulty in finding whether 
the patients had MDR tuberculosis. Nowadays, with the incidence of MDR TB on 
rise, chances of an Extrapulmonary TB to be a drug resistant one are very high. 
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  Conclusion: 
 Ileal stricture was the most common presentation of the acute 
abdominal tuberculosis. 
 Prior thorough investigations for Pulmonary Tuberculosis with 
sputum AFB  in patients chronic abdominal pain and early initiation 
of the treatment  will definitely decrease the progression into 
abdominal tuberculosis a significant number of patients. 
 Performing a proximal diversion, along with the definitive 
procedure, significantly decreases the incidence of anastomotic 
leaks. 
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ANNEXURE A: 
ABBREVATIONS USED: 
PERI.TB PERITONEAL TUBERCULOSIS 
PTB PULMORARY TUBERCULOSIS 
RIF RIGHT ILIAC FOSSA 
TEND TENDERNESS 
PRO PROBE 
MES MESENTERIC 
BX BIOPSY 
ATT ANTI TUBERCULOSIS TREATMENT 
POD POST OPERATIVE DAY 
FOLL FOLLOW 
COMPL COMPLICATIONS 
EXAM EXAMINATION 
CO.MOR CO MORBIDITY 
PRE PREVIOUS 
FIND FINDING 
PROD PROCUDURE 
ABD  ABDOMEN 
DIST DISTENSION 
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BS BOWEL SOUND 
DIL DILATED 
SMA SMALL 
BOW BOWEL 
ILEA ILEAL 
STRIC STRICTURE 
IC ILEOCAECAL 
PROX PROXIMAL 
M MALE 
F FEMALE 
GUAR GUARDING 
RIG RIGIDITY 
F.F. FREE FLUID 
PERIT PERITONEAL 
C/S CULTURE AND SENSITIVITY 
OMEN OMENTUM 
BIOP BIOPSY 
RTI RESPIRATORY TRACT INFECTION 
MAL MALIGNANCY 
IL ILEUM 
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HEM COLEC HEMICOLECTOMY 
STRIC PLAST STRICTUROPLASTY 
PERF PERFORATION 
PERIT PERITONEAL 
APPE APPENDICULAR 
OBS OBSTRUCTION 
YRS YEARS 
RESEC RESECTION 
ANAS ANASTAMOSIS 
LIM LIMITED 
FLU FLIUD 
ANAL ANALYSIS 
MIN MINIMAL 
ASCIT ASCITIS 
EVAL EVALUATION 
DIV DIVERSION 
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ANNEXURE B: 
MASTER CHART: 
S
.
N
O 
NAME A
G
E 
S
E
X 
I.P.NO: P
R
E
V  
H
I
S 
A
B
D
.P
AI
N 
SYMPTOMS EXAM C
O
.
M
O
R 
              INV P
R
E
.
T
B 
AT
T 
HI
S 
HIV FIND PRO COMPL FOLL.UP 
USG  CT 
ATT P
O
S
T 
O
P 
P
T
B 
1. ANANDHAN 3
2 
M 94597 +
/
6 
M
O
N 
FEVER, ABD. 
PAIN- 10 DAYS 
RIF 
TEND 
- RT. IL F PRO 
TEND 
- - - - MES. DISEASE MES.NODE 
BX 
- ATT 
ON 
14 
PO
D 
 
2
. 
RAJSEKAR 3
6 
M 97000 +
/
2 
M
O
N 
ABD. DIST – 
21/2 DAYS 
DIST. 
ABD 
IBS 
- 
 
DIL. SMA 
BOW 
SMA 
BOW 
OBS 
- - - ILE. STRIC STRIC 
PLASTY 
ANAS 
LEAK 
ATT 
ON 
14 
PO
D 
 
3
. 
MANOHAR 4
8 
M 34002 - ABD. DIST- 2 
DAYS 
DIST. 
ABD 
N BS 
S
H
T 
DIL. SMA 
BOW 
SMA 
BOW 
OBS ? 
IC TB 
Y
E
S 
5 
YR
S 
- IC TB WITH DIL 
PROX. SMA BOW 
LIMITED 
RESEC ANAS 
WOUND 
GAPING/
RTI 
ATT 
ON 
20 
PO
D 
+ 
4
. 
NAGAPPAN  5
5 
M 89186 +
/
1 
Y
R 
FEVER,ABD. 
PAIN- 2 DAYS 
 
GUAR
/RIG 
+ 
S
H
T 
F.F ABD MES. 
NOD/F.
F ABD 
- - - PERIT  ABSCESS PUS C/S 
MES. NODE/ 
OMEN BIOP 
WOUND 
INFECTIO
N 
ATT 
ON 
21 
PO
D 
 
5
. 
DEIVANAI 6
0 
F 76248 +
/
1Y
R 
ABD. 
PAIN&DIST 
31/2 DAYS 
RIF 
MASS 
DIST/
GUAR
/DIS 
+ 
D
M
/
S
H
T 
RIF 
MASS/DIL 
SMA BOW 
?TB/? MAL 
RIF 
MASS/
DIL SMA 
BOW 
?TB/? 
MAL 
- - - IC MASS WITH 
PROX. SMA BOW 
RT 
HEMICOLEC 
WITH PROX  
IL DIVER 
- ATT 
ON 
14 
PO
D 
+ 
6
. 
MUNUSAMY 4
2 
M 100128 - FEVER/ABD. 
PAIN/ABD. 
DIST 2 DAYS 
ABD 
TEND/
DIST/
- DIL.SMA.BO
WPRO TEND 
- - - - ILE.STRIC WITH 
MES NODES 
STRIC 
PLAST/MES 
NODE BX 
- ATT 
ON 
14 
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DBS PO
D 
7
. 
LAXMI 2
2 
F 64128 +
/
N
.K 
FEVER/ABD.PAI
N 1 ½ DAYS 
ABD 
TEND/
GUAR
/RIG 
- PRO.TEND/
F.F ABD 
- - - - ILE. STRIC/PROX 
PERF/ PERIT 
CONTAM 
RESEC  
ANAS/ PROX 
IL  DIVER  
- ATT 
ON 
14 
PO
D 
 
8
. 
MANI 4
6 
M 21346 +
/
3 
M
O
N 
ABD.DIST 
3DAYS 
ABD 
DIST/ 
DBS 
- DIL.SMA 
BOW 
IC MASS 
? 
MALIG/
?TB 
- - - IC MASS WITH 
PROX. SMA BOW 
RT 
HEMICOLECT 
ANAS. 
LEAK 
ATT 
ON 
20 
PO
D 
+ 
9
. 
YUVARAJAN 1
8 
M 17431 +
/
1 
M
O
N 
FEVER/ABD 
PAIN 7 DAYS 
LOWE
R ABD 
GUAR
/RIGI
D 
- RIF PRO 
TEND/APPE 
MASS 
- - - - MES.DISEASE PERIT 
BX/MES.NOD
E BX 
- ATT 
ON 
14 
PO
D 
 
1
0
. 
RAMAN 2
9 
M 13420 - ABD.DIST/PAIN 
2 DAYS 
ABD. 
DIST/
DBS 
- DIL.SMA SMA 
BOW 
OBS 
Y
E
S 
14 
YR
S 
- ILE.STRIC RESEC ANAS - ATT 
ON 
14 
PO
D 
+ 
11
. 
SAMSUDEEN 4
1 
M 9023 - ABD.DIST/PAIN 
2 1/2 DAYS 
ABD. 
DIST/
DBS 
- DIL.SMA SMA 
BOW 
OBS 
- - - ILE.STRIC STRIC 
PLAST/MES 
NODE BX 
ANAS 
LEAK 
ATT 
ON 
14 
PO
D 
 
1
2
. 
YUSUF 3
0 
M 24782 +
/ 
2 
M
O
N 
FEVER,ABD. 
PAIN- 1 1/2 
DAYS 
ABD. 
DIST/
DBS 
- DIL.SMA SMA 
BOW 
OBS 
- - - ILE.STRIC RESEC ANAS - ATT 
ON 
14 
PO
D 
+ 
1
3
. 
 
LOGANATHAN 2
9 
M 27145 +
/1 
M
O
N 
FEVER/ABD. 
PAIN/ABD. 
DIST 2 DAYS 
ABD 
TEND/
DIST/
DBS 
- DIL.SMA.BO
WPRO TEND 
?STRICT 
SMA 
BOW/P
ROX 
OBS 
- - - IC TB/ PROX. 
SMA BOW OBS 
LIM. RESEC - ATT 
ON 
14 
PO
D 
 
1
4
. 
HEMAVATHY 3
5 
F 30986 - FEVER/ABD. 
PAIN/DIST 3 
DAYS 
ABD 
TEND/
DIST/
DBS 
- DIL BOW 
LOOPS 
SMA 
BOW 
OBS 
- - - ILE.STRIC STRIC 
PLAST/MES 
NODE BX 
- ATT 
ON 
14 
PO
D 
 
1
5
. 
MALINI 2
4 
F 45693 +
/ 
1 
M
O
ABD. DIST  2  ½  
DAYS 
ABD 
TEND/
DIST/
DBS 
- DIL BOW 
LOOPS 
DIL 
BOW 
LOOPS 
Y
E
S 
10 
YR
S 
- ILE.STRIC RESEC ANAS - ATT 
ON 
14 
PO
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N D 
1
6
. 
SEKARAN 3
7 
M 48923 +
/
3 
M
O
N 
FEVER/ABD. 
PAIN/ABD. 
DIST 2 DAYS 
ABD 
TEND/
DIST/
DBS 
- RIF PRO 
TEND/APPE 
MASS 
IC MASS 
? 
MALIG/
?TB 
- - - IC TB/ PROX. 
SMA BOW 
OBS/PERITON 
CONTAM 
LIM. RESEC - ATT 
ON 
14 
PO
D 
 
1
7
. 
RAJENDIRAN 4
3 
M 57892 +
/
2 
M
O
N 
FEVER/ABD. 
PAIN/ABD. 
DIST 4 DAYS 
ABD 
TEND/
DIST/
DBS 
- DIL BOW 
LOOPS 
DIL 
BOW 
LOOPS 
Y
E
S 
3 
YR
S 
- IC TB/ PROX. 
SMA BOW OBS/ 
LIM. RESEC WOUND 
GAPING/ 
RTI 
ATT 
ON 
14 
PO
D 
+ 
1
8
. 
REVATHY 3
4 
F 42157 +
/
3 
M
O
N 
ABD PAIN/ 
FEVER 4 DAYS 
GUAR
D/RIG
ID + 
- PROB 
TEND/F.F 
F.F. - - - PERIT  ABSCESS PUS C/S 
MES. NODE/ 
OMEN BIOP 
WOUND 
INFECTIO
N 
ATT 
ON 
24 
PO
D 
 
1
9
. 
MUNIYAN 4
7 
M 45221 +
/
4
M
O
N 
FEVER/ABD. 
PAIN/ABD. 
DIST 4 DAYS 
ABD 
DIST/
DBS 
S
H
T 
PROB 
TEND/F.FDI
L SMA BOW 
F.F. - - - IC TB  WITH 
PROX. SMA 
BOW/ASCIT 
RT 
HEMICOLECT
/ASCIT FLU 
ANAL 
- ATT 
ON 
14 
PO
D 
 
2
0
. 
THANGAVEL 3
9 
M 36771 - ABD PAIN/ABD 
DIST 3 DAYS 
ABD 
DIST/
DBS 
- DIL.SMA 
BOW 
DIL 
BOW 
LOOPS 
- - - ILE.STRIC RESEC ANAS ANAS. 
LEAK/SEP
T/DEATH 
  
2
1. 
DAMODHARAN 4
0 
M 43612 - FEVER/ABD. 
PAIN/ABD. 
DIST 2 ½ DAYS 
ABD 
DIST/
DBS 
- DIL.SMA 
BOW 
DIL 
BOW 
LOOPS 
- - - ILE.STRIC STRIC 
PLASTY 
- ATT 
ON 
14 
PO
D 
+ 
2
2
. 
SUNDARI 4
6 
F 57213 + 
2 
M
O
N 
FEVER/ABD 
PAIN ABD DIST 
3 DAYS/ 
ABD 
DIST/
DBS 
- PROB 
TEND/ DIL 
SMA BOW 
DIL 
BOW 
LOOPS 
- - - IC TB/DIL SMA 
BOW LOOPS 
RT 
HEMICOLECT
/ASCIT FLU 
ANAL 
WOUND 
INFECTIO
N 
ATT 
ON 
18 
PO
D 
 
2
3
. 
GOMATHI 4
3 
F 47117 +
/ 
1 
1/
2
M
O
N 
ABD 
PAIN/FEVER 
RIF 
TEND/ 
MIN 
RIF 
GUAR
D 
- PROB TEND ?APP 
ABSCES
S 
- - - MES. TB/ MIN 
ASCIT 
MES.NODE 
BX/ASCT 
ANAL 
- ATT 
ON 
16 
PO
D 
+ 
2
4
SARAVANAN 2
7 
M 37169 - FEVER/ABD 
PAIN ABD DIST 
ABD 
DIST/
- DIL.SMA 
BOW 
DIL 
BOW 
- - - ILE.STRIC/ MES 
TB 
STRIC 
PLASTY/MES. 
ANAS.LEA
K 
/WOUND 
ATT 
ON 
19 
 
82 
 
. 4 DAYS DBS LOOPS NODE BX INFECTIO
N 
PO
D 
2
5
. 
HARIHARAN 1
7 
M 68711 +
/
3 
Y
R
S 
ABD PAIN/ABD 
DIST 2 2/2  
DAYS 
ABD 
DIST/
IBS 
- PROB 
TEND/DIL.S
MA BOW 
DIL 
BOW 
LOOPS 
Y
E
S 
5 
YR
S 
- ILE.STRIC RESEC ANAS - ATT 
ON 
14 
PO
D 
 
2
6
. 
MICHAEL 3
6 
M 57357 - FEVER/ABD. 
PAIN/ABD. 
DIST 23½ DAYS 
ABD 
DIST/
ABS 
- PROB 
TEND/ DIL 
SMA BOW 
- - - - ILE STRIC/ DIL 
SMA BOW / 
PERITON  
RESEC 
ANAS/PROX 
DIVER  
- ATT 
ON 
25 
PO
D 
 
2
7
. 
PANDIAN 3
9 
M 12901 - FEVER/ABD. 
PAIN2 DAYS 
ABD 
TEND/
GUAR
D 
- ASCT FOR 
EVAL. 
E/O 
REE 
FLUID 
Y
E
S 
12 
YR
S 
- ASCIT / MES. TB ASCIT EVAL/ 
MES NODE BX 
- ATT 
ON 
14 
PO
D 
 
2
8
. 
SUBRAMANIAN 5
7 
M 45190 +
/ 
5 
M
O
N 
ABD DIST/ABD 
PAIN 4 DAYS 
ABD 
TEND/ 
ABD 
DIST 
D
M 
?CECAL 
MALIG 
?GROW
TH 
CECUM 
- - - IC GROWTH/DIL 
SMA BOW 
RT 
HEMICOLEC/
PROX SMA 
DIV 
- ATT 
ON 
30 
PO
D 
+ 
2
9 
RASHEED 2
2 
M 23145 +
/
3 
½ 
M
O
N 
ABD DIST/ABD 
PAIN 2 DAYS 
ABD 
TEND/ 
ABD 
DIST 
- DIL.SMA 
BOW 
DIL 
BOW 
LOOPS 
- - - ILE STRIC/ DIL 
SMA BOW / 
RESEC 
ANAS/PROX 
DIVER  
- ATT 
ON 
14 
PO
D 
- 
3
0
. 
 
RAMACHANDRAN 4
8 
M 56123 - FEVER/ABD 
PAIN ABD DIST 
3 DAYS/ 
ABD 
DIST/
DBS 
- PROB 
TEND/ DIL 
SMA BOW 
DIL 
BOW 
LOOPS 
- - - ILE STRIC/ DIL 
SMA BOW / 
PERITON  
RESEC ANAS  ATT 
ON 
14 
PO
D 
 
3
1. 
THANGARAJ 3
0 
M 24178 +
/ 
2 
M
O
N 
ABD PAIN/ABD 
DIST 21/2 
DAYS 
RIF 
MASS
ABD 
DIST/ 
D BS 
- RIF MASS 
FOR EVAL 
RIF 
MASS 
FOR 
EVAL/ 
SMA 
BOW 
OBS 
Y
E
S 
3 
YR
S 
- IC TB LIM RESEC/ 
DIV ILEO 
- ATT 
ON 
16 
PO
D 
 
3
2
. 
MUNIYAMMA 4
5 
F 119803 - FEVER/ABD 
PAIN 3 DAYS 
MIN 
DIFF 
GUAR
D/RIG
ID 
- PROB TND - - - - MES TB MES NODE BX - ATT 
ON 
12 
TH 
DAY 
+ 
3
3
CHANDRAN 3 M 21478 +
/ 
ABD PAIN/ABD ABD 
DIST/ 
- DIL SMA DIL SMA 
BOW/?
- - - ILE STIRC RESEC ANAS - ATT 
ON 
 
83 
 
. 3 1 
M
O
N 
DIST 2 DAYS N BS BOW STIR 12 
TH 
DAY 
3
4
. 
POORNIMA 2
9 
F 67129 +
/
3 
M
O
N 
ABD PAIN/ABD 
DIST 3 ½  DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
- - - - ILE STIRC STRIC. PLAST - ATT 
ON 
12 
TH 
DAY 
 
3
5
. 
KOTTI 4
6 
M 58267 - FEVER/ ABD 
PAIN/ABD DIST 
2 ½  DAYS 
ABD 
DIST/
NBS 
- DIL SMA 
BOW 
DIL SMA 
BOW/?
STIR 
Y
E
S 
4 
YR
S 
YES IC TB DIV. ILEO SEPT/DE
ATH 
 + 
3
6
. 
VALLI 3
0 
F 19245 - FEVER/ABD 
PAIN/ABD DIST 
4 ½  DAYS 
ABD 
DIST/
DBS/ 
GUAR 
RIGID 
- DIL SMA 
BOW/ IC 
MASS 
RIF 
MASS 
FOR 
EVAL/ 
SMA 
BOW 
OBS 
- - - IC TB LIM RESEC/ 
DIV ILEO 
WOUND 
INFECTIO
N 
ATT 
ON 
24 
TH 
DAY 
 
3
7
. 
SASIKUMAR 2
8 
M 102381 +
/ 
4 
M
O
N 
ABD PAIN/ABD 
DIST3 ½  DAYS 
ABD 
DIST/
DBS 
- PROB 
TEND/ DIL 
SMA BOW 
DIL 
BOW 
LOOPS 
- - - ILE STIRC RESEC ANAS - ATT 
ON 
20 
PO
D 
+ 
3
8
. 
PONNI 4
1 
F 73417 - ABD PAIN/ABD 
DIST 1 DAY 
ABD 
DIST/
I BS 
- DIL SMA 
BOW 
- - - - ILE STIRC RESEC ANAS - ATT 
ON 
14 
PO
D 
 
3
9
. 
SELVAM 3
0 
M 47223 +
/ 
1 
Y
R 
FEVER/ABD 
PAIN/ABD DIST 
4 DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
DIL 
BOW 
LOOPS 
- - - ILE STIRC STRIC. PLAST ANAS 
LEAK 
ATT 
ON 
18 
PO
D 
 
4
0
. 
ANANDHAN 4
5 
M 71905 +
/  
I 
½ 
M
O
N 
FEVER/ABD 
PAIN 2 DAYS 
DIFF 
GUAR
D 
RIGID 
D
M 
PROB TND N - - - MES. TB/ MIN 
ASCIT 
MES NODE BX - ATT 
ON 
14 
PO
D 
 
4
1. 
SHANMUGAM 5
7 
M 89157 +
/ 
5 
M
O
N 
FEVER/ABD 
PAIN 2 ½  DAYS 
DIFF 
GUAR
D 
RIGID 
- PROB TND N - - - MES. TB/ MIN 
ASCIT 
MES NODE BX - ATT 
ON 
18 
PO
D 
+ 
84 
 
4
2
. 
KAMALA 3
4 
F 56027 - ABD DIST 2 
DAYS 
ABD 
DIST/
DBS 
- RIF MASS 
FOR EVAL/ 
SMA BOW 
OBS 
CECAL 
MASS 
/PROX 
SMA 
BOW 
OBS 
- - - IC TB/DIL SMA 
BOW LOOPS 
RT 
HEMIC0LEC/ 
DIV ILEO 
SEPT/DE
ATH 
  
4
3
. 
CHINNASAMY 3
7 
M 19842 - FEVER/ABD 
PAIN/ABD DIST 
1 DAY 
ABD 
DIST/
DBS 
- ? RIF MASS 
EVAL 
- - - - IC TB/DIL SMA 
BOW LOOPS 
LIM RESEC WOUND 
INFECTIO
N/RTI 
ATT 
ON 
14 
PO
D 
 
4
4
. 
MARIAPOOSANAM 2
9 
M 2315 - ABD PAIN/ABD 
DIST 1 ½  DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
DIL SMA 
BOW 
- - - ILE STIRC STRIC. PLAST ANAS. 
LEAK 
ATT 
ON 
20 
PO
D 
 
4
5
. 
SUNDARAMBAL 4
3 
F 52310 +
/ 
2 
½ 
M
O
N 
ABD PAIN/ABD 
DIST 4 DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
DIL SMA 
BOW 
- - - ILE STIRC RESEC ANAS - ATT 
ON 
14 
PO
D 
 
4
6
. 
CHELLAPPAN 3
9 
M 50115 + 
4 
M
O
N 
ABD PAIN/ABD 
DIST 3 ½  DAYS 
ABD 
DIST/
DBS 
- PROB 
TEND/DIL 
SMA BOW 
? IC 
MASS/
SMA 
BOW 
OBS 
- - - IC TB/DIL SMA 
BOW LOOPS 
RT 
HEMICOLEC 
WOUND 
INFECTIO
N 
ATT 
ON 
16 
PO
D 
 
4
7
. 
THANIGAIMANI 2
2 
M 60338 +
/ 
8 
M
O
N 
ABD PAIN/ABD 
DIST 4  ½  
DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
DIL SMA 
BOW 
   ILE STIRC RESEC ANAS - ATT 
ON 
24 
PO
D 
+ 
4
8
. 
MUMTAJ 3
0 
F 1907 - FEVER/ABD 
PAIN/ABD DIST 
3 DAYS 
ABD 
DIST/
DBS 
- RIF MASS 
FOR EVAL/ 
SMA BOW 
OBS 
- - - - IC TB/DIL SMA 
BOW LOOPS 
RT 
HEMICOLEC 
- ATT 
ON 
20 
PO
D 
 
4
9
. 
PETER 3
3 
M 89177 - ABD PAIN 3 ½  
DAYS 
DIFF 
GUAR
D 
RIGID 
S
H
T 
FF ABD - - - - MES. TB/ MIN 
ASCIT 
MES NODE BX - ATT 
ON 
14 
PO
D 
 
5
0
. 
MOHAN 2
1 
M 60221 +
/ 1 
M
O
NT 
ABD PAIN/ABD 
DIST 2 ½  DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
DIL SMA 
BOW 
   ILE STIRC RESEC ANAS - ATT 
ON 
15 
PO
D 
 
85 
 
5
1. 
PRIYA 1
7 
F 53267 - ABD PAIN/ABD 
DIST 1  ½  DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
DIL SMA 
BOW 
   ILE STIRC RESEC ANAS - ATT 
ON 
13 
PO
D 
 
5
2
. 
SUNDARAM 2
6 
M 78156 +
/ 1 
M
O
N 
FEVER/ABD 
PAIN 1  ½  DAYS 
GUAR
D/ 
RIGID 
 N - - - - MES. TB  MES. NODE/ 
OMEN BIOP 
- ATT 
ON 
21 
PO
D 
 
5
3
. 
RAGAVI 2
6 
F 57122 - FEVER/ABD 
PAIN 2 ½  DAYS 
DIFF 
GUAR
D 
RIGID 
-  PROB TEND - - - - MES. TB MES NODE BX - ATT 
ON 
20 
PO
D 
 
5
4
. 
ABDULLAH 2
8 
M 49012 - FEVER/ABD 
PAIN 4  DAYS 
DIFF 
GUAR
D 
RIGID 
-  PROB TEND ASCIT 
FOR 
EVAL 
- - - MES. TB/ MIN 
ASCIT 
 MES. NODE/ 
OMEN BIOP 
- ATT 
ON 
14 
PO
D 
 
5
5
. 
KARUPANNAN 2
7 
M 73671 +/
3 
MO
N 
ABD PAIN/ABD 
DIST 2   DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
DIL SMA 
BOW 
- - - ILE STIRC RESEC ANAS ANAS. 
LEAK/SEP
T/DEATH 
  
5
6
. 
MARY 3
1 
F 11903 - ABD PAIN/ABD 
DIST 3  ½  
DAYS 
ABD 
DIST/
DBS 
- DIL SMA 
BOW 
- - - - ILE STIRC RESEC ANAS WOUND 
INFECTIO
N 
ATT 
ON 
15 
PO
D 
+ 
5
7
. 
VELMURUGAN 4
2 
M 29011 - ABD PAIN/ABD 
DIST 5  ½  
DAYS 
ABD 
DIST/
DBS 
- DIL   BOW 
LOOPS 
? 
GROWT
H 
TRANSV 
COLON 
- - - TRAN COLON 
MASS 
EXT RT 
HEMICOLEC/ 
PROX. DIV 
WOUND 
GAPING 
ATT 
ON 
27 
PO
D 
 
5
8
. 
RAGHU 2
8 
M 51098 - FEVER/ABD 
PAIN 3  ½  
DAYS 
GUAR
D/ 
RIGID 
- N - - - - MES. TB  MES. NODE/ 
OMEN BIOP 
- ATT 
ON 
14 
PO
D 
 
5
9
. 
THOMAS 2
8 
M 30991 +/
1 ½ 
MO
N 
ABD PAIN/ABD 
DIST 3  DAYS 
ABD 
DIST/
DBS 
 DIL SMA 
BOW 
    ILE STIRC RESEC ANAS WOUND 
INFECTIO
N 
ATT 
ON 
15 
PO
D 
 
6
0
. 
PERUMAL 4
7 
M 40914 - FEVER/ABD 
PAIN/ MASS 10 
DAYS 
MASS 
RIF 
- APPEND 
ABSCESS/? 
MASS 
? 
PSOAS 
ABSCES
S/ ? IC 
MASS 
- - - RETRO PERIT 
NODES IN RIF 
NODE BX WOUND 
INFECTIO
N/RTI 
ATT 
ON 
16 
POD 
+ 
86 
 
6
1. 
DHAMODHARAN 4
7 
M 10319 - FEVER/ABD 
PAIN 3  ½  
DAYS 
GUAR
D 
RIGID 
- F.F  ASCIT 
FOR 
EVAL 
- - - PERIT  ABSCESS PUS C/S 
MES. NODE/ 
OMEN BIOP 
WOUND 
INFECTIO
N 
ATT 
ON 
17 
POD 
 
6
2
. 
 
RANI 3
2 
F 81023 +/ 
3 
MO
N 
ABD PAIN/ABD 
DIST 4  ½   
DAYS 
RIF 
MASS
/ABD 
DIST/
IBS 
D
M
S
H
T 
RIF MASS 
FOR EVAL 
- - - YES IC TB/DIL SMA 
BOW LOOPS 
RT 
HEMICOLEC/
DIV ILEO 
- ATT 
ON 
17 
POD 
+ 
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ANNEXURE C: 
QUESTIONNAIRE 
PATIENT DETAILS: 
ON ADMISSION: 
Name : 
Age : 
Sex : 
IP No. : 
Duration of symptoms : 
Co-morbid illness : 
DM : yes / no    IHD / CAD : yes / no 
HT : yes / no 
H/O previous abdominal pain in recent past: yes/no   if yes, duration: 
H/O taking drugs for TB : yes / no 
Whether the patient completed the duration of treatment: yes/no 
If completed treatment, time since the completion of treatment: 
CLINICAL EXAMINATION: 
Pulse : 
BP : 
Anemia : yes / no 
88 
 
Icterus : yes / no 
Pedal edema : yes / no 
CVS:                                                               P/R: 
RS: 
P/A: 
INVESTIGATIONS : 
Hemogram: 
Renal Function Test: 
Liver Function Test: 
HIV 1&2: 
USG ABD: 
CECT ABD: 
INTERVENTION DONE: - 
 DETAILS OF INTERVENTION: 
POST OP : - 
GROSS MORPHOLOGICAL APPEARANCE OF THE SPECIMEN: 
HISTOPATHOLOGICAL SPECIMEN REPORT 
 
 
 
